Accepted abstracts

Oral Communication

Poster Discussion

Poster Exhibition

Oral Communication Sessions

Selected abstract will be presented in Oral Communication Sessions. The Authors of the selected abstract are requested to attend those sessions and provide max 12 (Microsoft Power Point) slides resuming their poster. Time allowed for presentation: 10 minutes followed by 2 minutes for discussion.

All Speakers are requested to start their presentations with a Disclosure of Potential Conflicts of Interest slide.

Poster Discussion Sessions

Selected abstract will be presented in Oral Discussion Sessions. The Authors of the selected abstract are requested to attend those sessions and provide max 3/4 (Microsoft Power Point) slides resuming their poster. Time allowed for presentation: 5 minutes followed by 2 minutes for discussion.

All Speakers are requested to start their presentations with a Disclosure of Potential Conflicts of Interest slide.

Authors can set up their posters according to the number received from the Organizing Secretariat on June 6, 2016 from h. 9.30 and remove them on June 8, 2016 at the end of the Congress.

Poster4you service for creating and printing your poster will be active until 20th May 2016.

Poster Exhibition

ICAR Poster exhibition will take place within a dedicated area of the Congress Center. Dimensions should not exceed 70x100 cm. Authors can set up their posters according to the number received from the Organizing Secretariat on June 6, 2016 from h. 9.30 and remove them on June 8, 2016 at the end of the Congress.

Poster4you service for creating and printing your poster will be active until 20th May 2016.

Financial Disclosure

All presenters should include a disclosure slide that lists all financial relationships with commercial entities (eg, pharmaceutical and diagnostic companies, etc). Sample wording is provided below.

Dr. [insert presenting author’s name] has no financial relationships with commercial entities to disclose.
Dr. [insert presenting author’s name] has served as a member of data monitoring committees for Company XX [insert company name]–sponsored clinical trials.
Dr. [insert presenting author’s name] received research grants awarded to his/her institution from Company XX [insert company name]
Dr. [insert presenting author’s name] is an employee of Company XX [insert company name].